Jane Street’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Jane Street’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,500	Closed	-$293K	–	9773
2021 Q1	$293K	Sell	3,500 -1,500	-30%	-$142K	﹤0.01%	7737
2020 Q4	$432K	Buy	5,000 +2,100	+72%	+$163K	﹤0.01%	5949
2020 Q3	$203K	Sell	2,900 -7,100	-71%	-$504K	﹤0.01%	6413
2020 Q2	$726K	Buy	10,000 +2,700	+37%	+$172K	﹤0.01%	4529
2020 Q1	$338K	Sell	7,300 -9,700	-57%	-$540K	﹤0.01%	4080
2019 Q4	$1.05M	Sell	17,000 -12,700	-43%	-$678K	﹤0.01%	2716
2019 Q3	$1.26M	Sell	29,700 -49,400	-62%	-$2.34M	﹤0.01%	2318
2019 Q2	$4.1M	Sell	79,100 -62,500	-44%	-$3.11M	0.01%	1213
2019 Q1	$7.86M	Buy	141,600 +108,500	+328%	+$5.85M	0.01%	826
2018 Q4	$1.39M	Sell	33,100 -109,800	-77%	-$5.73M	﹤0.01%	2138
2018 Q3	$9.95M	Sell	142,900 -45,900	-24%	-$3M	0.02%	613
2018 Q2	$10.8M	Buy	188,800 +21,100	+13%	+$1.15M	0.03%	576
2018 Q1	$9.23M	Buy	167,700 +55,900	+50%	+$3.35M	0.02%	580
2017 Q4	$6.27M	Sell	111,800 -20,500	-15%	-$1.16M	0.02%	748
2017 Q3	$8.1M	Buy	132,300 +93,700	+243%	+$5.33M	0.03%	601
2017 Q2	$2.06M	Sell	38,600 -75,900	-66%	-$3.7M	0.01%	1463
2017 Q1	$5.53M	Buy	114,500 +91,200	+391%	+$4.24M	0.02%	652
2016 Q4	$930K	Sell	23,300 -90,000	-79%	-$3.84M	﹤0.01%	2165
2016 Q3	$5.49M	Sell	113,300 -217,200	-66%	-$10.3M	0.03%	554
2016 Q2	$12.8M	Buy	330,500 +134,000	+68%	+$5.78M	0.06%	267
2016 Q1	$8.03M	Buy	196,500 +83,200	+73%	+$3.68M	0.05%	373
2015 Q4	$8.1M	Sell	113,300 -470,700	-81%	-$31.4M	0.05%	332
2015 Q3	$34M	Buy	584,000 +568,600	+3,692%	+$48.5M	0.21%	82
2015 Q2	$1.39M	Sell	15,400 -10,400	-40%	-$895K	0.01%	1271
2015 Q1	$2.04M	Sell	25,800 -2,200	-8%	-$163K	0.02%	852
2014 Q4	$1.76M	Sell	28,000 -57,800	-67%	-$3.39M	0.01%	734
2014 Q3	$4.46M	Sell	85,800 -45,200	-35%	-$2.19M	0.05%	312
2014 Q2	$6.08M	Buy	131,000 +118,600	+956%	+$4.68M	0.08%	223
2014 Q1	$495K	Buy	+12,400	New	+$563K	0.01%	1572

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

WWM

Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CCWM

Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

CWM

Crowley Wealth Management Wilmington, Delaware $126M AUM 23.04% 1-Year Est. Return

Jane Street's BIB Position: Q4 2024 in Review

Jane Street sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2024, closing a stake of 4,803 shares — an estimated $306K sold.

Jane Street first reported a position in BIB in Q4 2013 and held it in 27 quarters. The position peaked at $5.4M in Q1 2015. 24 funds tracked by Wall St. Rank hold BIB as of Q4 2024.

Jane Street reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2024 after selling out during the quarter.
Jane Street sold 4,803 ProShares Ultra NASDAQ Biotechnology shares in Q4 2024, an estimated $306K.
Jane Street first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2013 and held it in 27 quarters.
Jane Street's ProShares Ultra NASDAQ Biotechnology position peaked at $5.4M in Q1 2015.
24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.